Enzyme-Linked Immunosorbent Assay Testing Market Report 2026

Enzyme-Linked Immunosorbent Assay Testing Market Overview

• Enzyme-Linked Immunosorbent Assay Testing market size has reached to $3.04 billion in 2025 • Expected to grow to $4.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.2% • Growth Driver: Rising Incidence Of Infectious Disorders Driving Growth In ELISA Testing Market • Market Trend: Innovative ELISA Kits Enhance Diagnostic Accuracy And Quality Control In Biopharmaceuticals • North America was the largest region in 2025.

What Is Covered Under Enzyme-Linked Immunosorbent Assay Testing Market?

Enzyme-linked immunosorbent assay (ELISA) testing refers to a widely used laboratory technique designed to detect and quantify specific proteins, antigens, or antibodies in a sample. This method involves immobilizing an antigen or antibody on a solid surface, typically a microplate, and then using enzyme-linked antibodies or antigens to bind to the target molecule. The main types of enzyme-linked immunosorbent assay testing are direct enzyme-linked immunosorbent assay (ELISA), sandwich enzyme-linked immunosorbent assay (ELISA), indirect enzyme-linked immunosorbent assay (ELISA), multiple and portable enzyme-linked immunosorbent assays (ELISA), and competitive enzyme-linked immunosorbent assays (ELISA). Direct enzyme-linked immunosorbent assay (ELISA) testing refers to a method where an antigen is directly immobilized on a solid surface. It can be applicable for immunology, inflammation, infectious diseases, cancer, protein quantitation, and others and cater to various end users, including hospitals and diagnostic centers, research laboratories, and others.

What Is The Enzyme-Linked Immunosorbent Assay Testing Market Growth Forecast?

The enzyme-linked immunosorbent assay testing market size is expected to see strong growth in the next few years. It will grow to $4.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing adoption of automated laboratory workflows, rising demand for biomarker-based diagnostics, expansion of elisa applications in oncology and immunology, growing focus on early disease detection, increasing investment in clinical research infrastructure. Major trends in the forecast period include increasing adoption of high-throughput elisa platforms, rising demand for multiplex immunoassays, growing integration of automated sample processing, expansion of elisa use in clinical research, enhanced focus on assay sensitivity and accuracy.

Global Enzyme-Linked Immunosorbent Assay Testing Market Segmentation

1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA) 2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications 3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users Subsegments: 1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA 2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA 3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA 4) By Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA): Multiplex ELISA (Multi-Analyte ELISA), Portable / Point-of-Care (POC) ELISA, Microfluidic-Based ELISA, Quantitative Portable ELISA, Qualitative Portable ELISA 5) By Competitive Enzyme-Linked Immunosorbent Assay (ELISA): Direct Competitive ELISA, Indirect Competitive ELISA, Quantitative Competitive ELISA, Qualitative Competitive ELISA

What Is The Driver Of The Enzyme-Linked Immunosorbent Assay Testing Market?

The growing incidence of infectious disorders is expected to propel the growth of the enzyme-linked immunosorbent assay testing market going forward. Infectious disorders are diseases caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can spread between individuals and impact various body systems. The growing incidence of infectious disorders can be attributed to increased global travel and the rise of antimicrobial resistance, which complicates infection control. Enzyme-linked immunosorbent assay (ELISA) testing is helpful for infectious disorders as it allows for the accurate detection and quantification of specific antigens or antibodies related to the infection, aiding in diagnosis, monitoring disease progression, and evaluating treatment effectiveness. For instance, in February 2024, according to data published by the World Health Organization, a Switzerland-based intergovernmental public health organization, a total of 58114 measles (a highly contagious viral disease) cases were reported in the European Region in 2023, compared to 941 cases in 2022. Therefore, the growing incidence of infectious disorders is driving the growth of the enzyme-linked immunosorbent assay testing industry.

Key Players In The Global Enzyme-Linked Immunosorbent Assay Testing Market

Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc, Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio

Global Enzyme-Linked Immunosorbent Assay Testing Market Trends and Insights

Major companies in the enzyme-linked immunosorbent assay testing market are focusing on broadening their offerings through product innovations, such as novel enzyme-linked immunosorbent assay (ELISA) kits, to enhance diagnostic accuracy and meet diverse research and clinical needs. Novel Enzyme-Linked Immunosorbent Assay (ELISA) kits refer to advanced versions of ELISA tests that offer improved accuracy, sensitivity, and usability for detecting and quantifying biomarkers. For instance, in February 2023, Charles River Laboratories, a US-based pharmaceutical company, introduced a novel enzyme-linked immunosorbent assay (ELISA) kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics. This innovative kit utilizes avian immunoglobulin Y (IgY) antibodies sourced from specific pathogen-free (SPF) chicken eggs, providing enhanced sensitivity and specificity with detection limits as low as 0.1 ng/mL and 90% antibody coverage. This launch aims to improve quality control in biopharmaceutical development, ensuring the safety and efficacy of new therapies while allowing for flexible use by clients, either independently or with support from Charles River's experts.

What Are Latest Mergers And Acquisitions In The Enzyme-Linked Immunosorbent Assay Testing Market?

In February 2024, Dyadic International Inc., a US-based biotechnology company, partnered with Cygnus Technologies to offer a C1 HCP enzyme-linked immunosorbent assay, aimed at improving quality assurance in biomanufacturing. The collaboration focuses on quantifying host cell proteins (HCPs) derived from Dyadic's proprietary C1 cells, which are based on the filamentous fungus Thermothelomyces heterothallica. Cygnus Technologies LLC is a US-based biopharmaceutical company.

Regional Outlook

North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Enzyme-Linked Immunosorbent Assay Testing Market?

The enzyme-linked immunosorbent assay testing market consists of revenues earned by entities providing services such as diagnostic testing, research and development, detection of antibodies, and vaccine development. The market value includes the value of related goods sold by the service provider or included within the service offering. The enzyme-linked immunosorbent assay testing market also includes sales of ELISA kits, control samples, inhibitor assays, and other consumables such as microplate readers, washers, and automated ELISA systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Enzyme-Linked Immunosorbent Assay Testing Market Report 2026?

The enzyme-linked immunosorbent assay testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme-linked immunosorbent assay testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.